Literature DB >> 9612912

Studies on the efficacy of hyperbaric rendering procedures in inactivating bovine spongiform encephalopathy (BSE) and scrapie agents.

B E Schreuder1, R E Geertsma, L J van Keulen, J A van Asten, P Enthoven, R C Oberthür, A A de Koeijer, A D Osterhaus.   

Abstract

The efficacy of the procedures in use at the two rendering plants in the Netherlands was assessed on a laboratory-scale using procedures that simulated the pressure cooking part of the rendering process. A pool of bovine spongiform encephalopathy (BSE)-infected brainstem from the United Kingdom and a pool of scrapie-infected brainstem from Dutch sheep were used to spike the rendering materials. The mixtures were subjected to various time-temperature combinations of hyperbaric heat treatment related to the conditions used in Dutch rendering plants in the early 1990s, and to the combination of 20 minutes at 133 degrees C required by the EU Directive on rendering of 1996. The efficacy of the procedures in inactivating BSE or scrapie infectivity was measured by titrating the materials before and after heat treatment in inbred mice, by combined intracerebral and intraperitoneal inoculations at limiting dilutions. Two independent series of experiments were carried out. The design of the study allowed for minimum inactivations of up to 2.2 log (2.0 in the second series) to be measured in the diluted infective material and 3.1 log in the undiluted material. After 20 minutes at 133 degrees C there was a reduction of BSE infectivity of about 2.2 log in the first series (with some residual infectivity detected), and in the second series more than 2.0 log (with no residual infectivity detected). With undiluted brain material there was an inactivation of about 3.0 log (with some residual infectivity detected). With the same procedure, scrapie infectivity was reduced by more than 1.7 log in the first series and by more than 2.2 log in the second series. With undiluted brain material there was an inactivation of more than 3.1 log. In each case no residual scrapie infectivity was detected. The BSE agent consistently appeared to be more resistant to heat inactivation procedures than the scrapie agent, particularly at lower temperatures and shorter times.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9612912     DOI: 10.1136/vr.142.18.474

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  5 in total

1.  [Variant Creutzfeldt-Jakob disease. Epidemiology, detection, diagnosis and prevention with special reference to minimizing risk of iatrogenic transmission by medical products, especially surgical instruments. Report of the Variant Creutzfeldt-Jakob Disease Task Force on this topic].

Authors: 
Journal:  HNO       Date:  2002-04       Impact factor: 1.284

2.  A temporal-spatial analysis of bovine spongiform encephalopathy in Irish cattle herds, from 1996 to 2000.

Authors:  Hazel A Sheridan; Guy McGrath; Paul White; Richard Fallon; Mohamed M Shoukri; S Wayne Martin
Journal:  Can J Vet Res       Date:  2005-01       Impact factor: 1.310

3.  Quantifying BSE control by calculating the basic reproduction ratio R0 for the infection among cattle.

Authors:  Aline de Koeijer; Hans Heesterbeek; Bram Schreuder; Radulf Oberthür; John Wilesmith; Herman van Roermund; Mart de Jong
Journal:  J Math Biol       Date:  2003-06-12       Impact factor: 2.259

4.  Rapid assessment of bovine spongiform encephalopathy prion inactivation by heat treatment in yellow grease produced in the industrial manufacturing process of meat and bone meals.

Authors:  Miyako Yoshioka; Yuichi Matsuura; Hiroyuki Okada; Noriko Shimozaki; Tomoaki Yamamura; Yuichi Murayama; Takashi Yokoyama; Shirou Mohri
Journal:  BMC Vet Res       Date:  2013-07-09       Impact factor: 2.741

5.  Stability of BSE infectivity towards heat treatment even after proteolytic removal of prion protein.

Authors:  Jan P M Langeveld; Anne Balkema-Buschmann; Dieter Becher; Achim Thomzig; Romolo Nonno; Olivier Andréoletti; Aart Davidse; Michele A Di Bari; Laura Pirisinu; Umberto Agrimi; Martin H Groschup; Michael Beekes; Jason Shih
Journal:  Vet Res       Date:  2021-04-16       Impact factor: 3.683

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.